KDM6A and leukemia: The identification of recurrent inactivating UTX mutations in several leukemia and solid tumor cases strongly supports that UTX acts as a tumor suppressor for human cancers.33, 34, 35 However, the roles of UTX in cancer development and progression appear to be more complicated than initially expected.